Following ‘CRISPR Babies’ Scandal, Senators Call for International Gene Editing Guidelines
By Andrew Joseph,
STAT+
| 07. 15. 2019
A bipartisan trio of senators has introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
A bipartisan trio of senators on Monday introduced a resolution underscoring their opposition to the experiments last year in China that led to the birth of the world’s first genome-edited babies.
The resolution from Sens. Dianne Feinstein (D-Calif.), Marco Rubio (R-Fla.), and Jack Reed (D-R.I.) also reiterated support for international groups working to produce guidelines for the clinical use of germline editing — meaning changes to the DNA in sperm, eggs, or early embryos that would be passed down to future generations.
If passed, the resolution would not change U.S. law; editing embryos with the purpose of creating children is already illegal in the United States. But the action by the senators stands out, since some members of Congress have recently expressed some openness to lifting the ban on editing embryos used to start pregnancies. Scientists in other countries have also announced plans to continue pursuing such experiments, and some scientific and patient advocacy groups have emphasized how germline editing, once the technology improves, could stave off cases of genetic disease.
“Gene editing is a powerful technology that...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...